BALTIMORE—John Richie, Ph.D., will discuss glutathione’s role in detoxification, the causes of glutathione depletion and deficiency, and current supporting data on bioavailability of orally administered glutathione at the 20th Annual International and American Associations of Clinical Nutritionists (IAACN) Scientific Symposium on Thursday, Aug. 18, at 5:30 p.m. at the Baltimore Marriott Waterfront Hotel.
Richie, professor of public health sciences and pharmacology with Penn State University College of Medicine will also explain the relationship between oxidative stress and disease, and redox reactions and as an antioxidant in his presentation, "Role of Glutathione in Protection Against Oxidative Stress and Related Diseases."
Glutathione is a tri-peptide, made from glutamic acid, cysteine and glycine. Glutathione increases the effectiveness of the body's other antioxidants such as vitamin C and E, and is involved in various reactions, such as the destruction of free radicals and the detoxification of harmful compounds.
An oral dose of glutathione increased blood, tissue and extracellular glutathione levels, and the absorption of glutathione was dependent on the cystic fibrosis transmembrane conductance regulator, according to a 2010 study that used Setria® glutathione from Kyowa Hakko USA.
